Literature DB >> 6416062

Subjective assessment of patient outcomes of home parenteral nutrition.

R A Robb, J I Brakebill, M F Ivey, D B Christensen, J H Young, B H Scribner.   

Abstract

The medical, financial and psychosocial impact of home parenteral nutrition (HPN) therapy on patients' lives was assessed. A questionnaire that solicited patient characteristics and therapeutic outcomes of HPN therapy, such as number of hospital admissions, physiological complaints, and psychosocial interferences, was sent to 49 patients currently participating in a HPN program based at a university hospital. Questionnaires were returned by 42 patients. HPN-related complications were responsible for 39% of all reported hospital admissions during the previous year; of these, 27% were related to HPN catheters. Patients reported few physiological complaints, except for cramping in the hands and feet. Patients who complained of diarrhea had significantly more physiological complaints and psychosocial interferences than those who did not. The majority of patients had medical insurance coverage, but 26% had to pay at least part of the costs of HPN therapy. Only 25% of patients who were able to work did so. Most patients believed that HPN therapy had a very positive effect on their lives. The majority of patients in this HPN program appear to have a reasonable quality of life.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6416062

Source DB:  PubMed          Journal:  Am J Hosp Pharm        ISSN: 0002-9289


  3 in total

Review 1.  Comprehensive care of the patient with gut failure: present and future.

Authors:  C R Fleming
Journal:  Trans Am Clin Climatol Assoc       Date:  1987

Review 2.  Quality of life of patients receiving home parenteral or enteral nutrition support.

Authors:  M Malone
Journal:  Pharmacoeconomics       Date:  1994-02       Impact factor: 4.981

Review 3.  Economics of home parenteral nutrition.

Authors:  A Cade; J Puntis
Journal:  Pharmacoeconomics       Date:  1997-09       Impact factor: 4.981

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.